autologous cd4 t-cells
Cell therapyexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2017 (NCT03020524)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- T-lymphocytesSupplementation
T-lymphocytes supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- autologous cd4 t-cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03666871 | Phase 1/Phase 2 (Phase 2) | Dec 2, 2018 | Case Western Reserve University, University of California, San Francisco, University of Cincinnati |
| NCT03020524 | Early Phase 1 (Phase 1) | Jan 1, 2017 | University of Pennsylvania |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Case Western Reserve University | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of California, San Francisco | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of Cincinnati | Academic/Hospital | 1 | 1 | 1 | 2018 |
| University of Pennsylvania | Academic/Hospital | 1 | 1 | 1 | 2017 |
4 organizations
Page 1 / 1